Cardiogenic shock (CS) patients receiving temporary mechanical circulatory support (tMCS)
Temporary mechanical circulatory support (tMCS)
Current landmark trials for temporary mechanical circulatory support in cardiogenic shock lack generalizability to the broader real-world patient population, necessitating enhanced registry enrollment and innovative analytic strategies.
Patients meeting the landmark CS trial criteria represent a small, high-risk subset of the real-world CS population, highlighting a substantial evidence gap for the majority of CS patients receiving tMCS in clinical practice. Enhancing registry enrollment of specific CS subsets and adopting innovative analytic strategies could bridge gaps between randomized controlled trials findings and real-world applicability.
Building similarity graph...
Analyzing shared references across papers
Loading...
Song Li
Claudius Mahr
Rachna Kataria
JACC Advances
University of Chicago
Massachusetts General Hospital
Brown University
Building similarity graph...
Analyzing shared references across papers
Loading...
Li et al. (Tue,) studied this question.
www.synapsesocial.com/papers/69d892d16c1944d70ce0413a — DOI: https://doi.org/10.1016/j.jacadv.2026.102723